Tyrosine kinase inhibitors in patients with neuroendocrine neoplasms: a systematic literature review

Autor: Rodrigo G. Taboada, Felicia P. Cavalher, Juliana F. Rego, Rachel P. Riechelmann

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 16 (2024)

Background: Several tyrosine kinase receptors inhibitors (TKIs) have demonstrated antiproliferative effects in well-differentiated neuroendocrine tumors (NETs). We aimed to summarize and appraise the current evidence of the efficacy of TKIs in patien

Externí odkaz: https://doaj.org/article/300a9cbeb3974a56a775fbefa9029f12

Survey NEN / Inquérito NEN

Autor: Carla Andressa Rodrigues Dias Fleury de Lima, Renata D'Alpino Peixoto, Rui F. Weschenfelder, Gabriel Prolla, Juliana F Rego, Duilio Rocha, Marcela Crosara, Gustavo Fernandes, Paulo M Hoff, Aline Chaves Andrade, Anelisa K. Coutinho, Rachel P. Riechelmann

Publikováno v: Brazilian Journal of Health Review; Vol. 5 No. 4 (2022); 12017-12029
Brazilian Journal of Health Review; v. 5 n. 4 (2022); 12017-12029
Brazilian Journal of Health Review
Federação das Indústrias do Estado do Paraná (FIEP)
instacron:BJRH

Introduction: Although new treatments and diagnostic methods for Neuroendocrine Neoplasms (NEN) have been introduced, the level of access to them needs somehow to be further investigated. Objectives: to understand the aspects that influence the acces

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff2ab1d130fa3abec187a4a71d6cb33
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/49858